Results 111 to 120 of about 74,283 (261)
Human Vaccines & Immunotherapeutics, 2019 Background. Improving human papilloma virus (HPV) vaccination coverage in the US will require healthcare providers to recommend the vaccine more effectively.
Kimberly K. Walker +4 more
doaj +1 more source
HPV vaccination bridges to HPV screening [PDF]
EClinicalMedicine, 2020 Harper, Diane M, Sheinfeld Gorin, Sherri
openaire +2 more sources
Acta Obstetricia et Gynecologica Scandinavica, EarlyView.Large‐scale HPV self‐sampling screening distributed 557 976 kits, resulting in 208 386 returned samples with 98% validity. HPV positivity was detected in 19% of participants, leading to clinical follow‐up. Biopsy confirmed 980 high‐grade cervical lesions and 32 cervical cancers.
Caroline Hellsten +2 more
wiley +1 more source
Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme
Acta Paediatrica, EarlyView.ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson +2 more
wiley +1 more source
BMC Public HealthBackground Men who have sex with men (MSM), especially those living with HIV, have a high prevalence of HPV infections that might lead to HPV-related diseases, including penile, oropharyngeal and anal carcinomas.
Cornelia Wähner +10 more
doaj +1 more source
Therapeutic potential of natural products in cancer immunotherapy: Advances and challenges
British Journal of Pharmacology, EarlyView.This review systematically outlines the mechanisms underlying tumour immunotherapy resistance and elucidates the role of natural products in enhancing therapeutic efficacy as immunomodulatory adjuvants. Abstract Immunotherapy has emerged as a clinically pivotal approach in cancer treatment, but its application remains limited to a small subset of ...
Rao Hu +6 more
wiley +1 more source
Human Vaccines & Immunotherapeutics, 2019 Despite high HPV prevalence and low vaccination rates in the military, HPV vaccination is not required upon military service initiation. Given that national HPV vaccination rates remain low among people age 19–26 years, military service may represent an ...
Tamar Nobel +3 more
doaj +1 more source
Cytopathology, EarlyView.The study introduces the CytoLog performance dashboard application for cytology laboratories featuring selected key performance indicators for management and staff. The application is adaptable to various laboratory settings, enhances engagement and interaction with quality, promotes self‐directed quality improvement, and helps mitigate potential bias ...
István Kovács +7 more
wiley +1 more source
HPV42 – a human papillomavirus classified as a low‐risk type with oncogenic potential
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary Human papillomavirus (HPV) type 42 is a rare HPV type currently classified as “low‐risk” and belongs to the alpha genus. It has primarily been detected in benign vulvar papillomas and is predominantly associated with benign lesions such as anogenital warts.
Sven Niklas Burmann +7 more
wiley +1 more source
S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.Summary In the project funded by the Innovation Committee at the G‐BA, the S3 guideline for the diagnosis and treatment of AA was developed between 2023 and 2025. The interdisciplinary expert panel consisted of representatives from the German Dermatological Society, in particular from the Pediatric Dermatology Working Group, the Professional ...
Ulrike Blume‐Peytavi +13 more
wiley +1 more source